Vaccines
22 December 2014
Medigene Receives Clinical Trial Approval for Phase I/II Study with DC Vaccine to Treat Acute Myeloid Leukaemia (AML)18 December 2014
Positive Outcome of Phase 3 Study of GSK Shingles Vaccine Containing Agenus Adjuvant18 December 2014
Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers18 December 2014
Valneva Announces Start of Phase II Clinical Trial of its Clostridium difficile vaccine candidate16 December 2014
Neovacs Announces Top Line Phase IIb Clinical Trial Results of TNF-Kinoid in Rheumatoid Arthritis and Update on Clinical Programs12 December 2014
Valneva Announces Publication of First Phase II Data of Tuberculosis Vaccine Candidate Formulated with IC31® Adjuvant12 December 2014
Batu Biologics Submits Investigational New Drug Application for Lung Cancer Anti-Angiogenic Immunotherapy with FDA9 December 2014
Circassia Announces Top-Line Results from Ragweed Allergy Treatment Phase IIb Chamber Study9 December 2014
PARKINSON’S VACCINE: EU-TEAM LAUNCHES CLINICAL TRIAL8 December 2014
VaxInnate Initiates Phase 1b/2 Clinical Trial of Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, in Elderly25 November 2014
Apitope Receives Orphan Designation in the European Union for ATX-F8-117 for the Treatment of Haemophilia A21 November 2014
Xenetic Biosciences Partner Completes First Patient Cohort in Phase 2 Study with MyeloXen™ for Multiple Sclerosis21 November 2014
STALLERGENES And ActoGenix To Develop An Innovative New Class Of Oral Allergy Treatments20 November 2014
Inovio Pharmaceuticals Melanoma DNA Immunotherapy Inhibits Tumor Growth and Increases Survival in Preclinical Study19 November 2014
SOTIO Initiates US part of VIABLE, a Global Phase III Clinical Trial for Prostate Cancer Immunotherapy Treatment with DCVAC/PCa19 November 2014
THERAVECTYS Provides Update on Its Phase I/II Lentiviral Vector-Based Therapeutic Vaccine Trial14 November 2014
Canada Begins Ebola Vaccine TrialNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports